The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Aunins John G. since year 2005.
The trader's CIK number is 1643756.
At the time of this reporting, Aunins John G. is the Chief Technology Officer & EVP of Seres Therapeutics, Inc. .
(stock ticker symbol MCRB).
See this page for all insider trading activities at Seres Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-07-15||MCRB||Seres Therapeutics, Inc.||Sale||14,279||8.11||115,731|
|2018-06-19||MCRB||Seres Therapeutics, Inc.||Option Ex||5,000||.00||0|
|2018-06-15||MCRB||Seres Therapeutics, Inc.||Sale||14,279||8.57||122,328|
|2018-04-25||MCRB||Seres Therapeutics, Inc.||Sale||14,279||7.58||108,263|
|2018-01-26||MCRB||Seres Therapeutics, Inc.||Option Ex||5,000||.00||0|
|2018-01-26||MCRB||Seres Therapeutics, Inc.||Sale||1,738||11.02||19,152|
|2017-12-19||MCRB||Seres Therapeutics, Inc.||Option Ex||5,000||.00||0|
|2017-12-19||MCRB||Seres Therapeutics, Inc.||Sale||1,623||10.14||16,457|
|2016-08-29||MCRB||Seres Therapeutics, Inc.||Sale||9,390||10.87||102,069|
|2016-07-27||MCRB||Seres Therapeutics, Inc.||Sale||9,250||35.00||323,750|
|2016-07-22||MCRB||Seres Therapeutics, Inc.||Option Ex||187,500||.48||90,000|
|2016-07-25||MCRB||Seres Therapeutics, Inc.||Sale||9,390||34.18||320,950|
|2016-06-27||MCRB||Seres Therapeutics, Inc.||Sale||9,390||27.23||255,689|
|2016-05-31||MCRB||Seres Therapeutics, Inc.||Sale||14,015||30.30||424,584|
|2016-04-25||MCRB||Seres Therapeutics, Inc.||Sale||18,640||31.94||595,361|
|2016-03-28||MCRB||Seres Therapeutics, Inc.||Sale||9,390||23.89||224,327|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aunins John G. (Chief Technology Officer & EVP of Seres Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.